Blood Pressure Monitoring Testing Market is forecast to Reach a Value of US$ 9,900.4 Mn by 2028

Checking blood pressure at home is an important part of managing high blood pressure. Home blood pressure monitoring is essential to preventing heart disease and strokes. Blood pressure transducers include reusable transducers and disposable transducers and blood pressure managing accessories include bladders, bulbs, vales, and blood pressure cuffs.

Market Statistics:

The global Blood pressure monitoring testing market is expected to surpass US$ 9,900.4 Mn in terms of value by the end of 2028.

Global Blood Pressure Monitoring Testing Market: Drivers

Increasing prevalence of diabetes is expected to propel growth of the global blood pressure monitoring testing market over the forecast period. For instance, according to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.

Global Blood Pressure Monitoring Testing Market: Opportunities

R&D in blood pressure monitoring economies is expected to offer lucrative growth opportunities for players in the global blood pressure monitoring testing market. For instance, in September 2019, researchers from National Taipei University of Nursing and Health Sciences, Taiwan, reported that assessing the estimated Glomerular filtration rate, hypertension, body-mass index, and systolic blood pressure can be effective in modeling arterial stiffness risk assessments for community-dwelling individuals with a normal or slightly decreased estimated Glomerular filtration rate.

Global Blood Pressure Monitoring Testing Market: Recent Developments

On August 20, 2021, OMRON Healthcare India has announced the initiation of AI-based collaborative trial program in the field of remote patient monitoring. This program has aimed at patients that have undergone surgical procedures or ablation for the treatment of cardiovascular diseases, aims to establish the relevance & role of remote hypertension & ECG monitoring for strengthening the treatment & care regime to reduce cardiovascular complications and deaths

On June 24, 2021, OMRON Healthcare Co., Ltd., and Kyoto University, Japan has announced a new Collaborative Research Program called “Healthcare Medical AI to use artificial intelligence (AI) and an innovative data set of home measurements to prevent the events of cardiovascular disease.

In November 2020, Blipcare has launched New BP monitor Blip BP800 which has been launched for remote monitoring patients, and specifically designed to serve patients who need Remote Patient Monitoring (RPM).

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/blood-pressure-monitoring-testing-market-4617

Global Blood Pressure Monitoring Testing Market: Restraints

Product recalls are expected to hamper the market growth. For instance, in June 2018, Withings Sas recalled Nokia BPM+ Wireless Blood Pressure Monitor as the device failed to meet the requirements for systolic pressure.

Global Blood Pressure Monitoring Testing Market - Impact of Coronavirus (Covid-19) Pandemic

Globally, as of 6:16pm CEST, 3 September 2021, there have been 218,946,836 confirmed cases of COVID-19, including 4,539,723 deaths, reported to WHO. As of 1 September 2021, a total of 5,289,724,918 vaccine doses have been administered. Emergence of Covid-19 has led to increasing focus on health and lifestyle as people suffering from lifestyle diseases are at high risk of suffering from Covid-19. Such scenario is expected to boost adoption of blood pressure monitoring testing.   

 Key Takeaways:

• The global blood pressure monitoring testing market was valued at US$ 4,085.7 Mn in 2020 and is forecast to reach a value of US$ 9,900.4 Mn by 2028 at a CAGR of 11.7% between 2021 and 2028.
• The Automated/Digital Blood Pressure Monitors segment was valued US$ 954.7 Mn in 2020 and is expected to witness a CAGR of 14.6% over the forecast period.

Market Trends

Major players in the market are focused on increasing their production capacity in the wake of Covid-19 pandemic. For instance, in March 2020, Hillrom, Inc. announced that the company is doubling the production of ventilators, hospital beds, and vitals monitoring devices to support Covid-19 response.

Major players in the market are also focused on providing services and products to at-risk Medicare Advantage members. For instance, in December 2019, Royal Philips collaborated with Humana Inc. to help improve care and health outcomes for select high-risk Medicare Advantage members. Under the collaboration, Humana has implemented two programs that leverage Philips’ medical alert services and remote member monitoring solutions to actively monitor at-risk Medicare Advantage members.

Global Blood Pressure Monitoring Testing Market: Competitive Landscape   

Major players operating in the global blood pressure monitoring testing market include, A&D Medical, Inc., Contec Medical Systems Co., Ltd., Covidien Plc, GE Healthcare, Masimo Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., SunTech Medical, Inc., Nihon Kohden Corporation, Philips Healthcare, Spacelabs Healthcare, Omron Healthcare, Inc., Withings sas, and Welch Allyn, Inc. (Hill-Rom, Inc.)